Publication

Cost-effectiveness of controlling gestational diabetes mellitus: A systematic review

Fitria, N., van Asselt, A. D. I. & Postma, M. J., Apr-2019, In : European Journal of Health Economics. 20, 3, p. 407-417 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

APA

Fitria, N., van Asselt, A. D. I., & Postma, M. J. (2019). Cost-effectiveness of controlling gestational diabetes mellitus: A systematic review. European Journal of Health Economics, 20(3), 407-417. https://doi.org/10.1007/s10198-018-1006-y

Author

Fitria, Najmiatul ; van Asselt, Antoinette D. I. ; Postma, Maarten J. / Cost-effectiveness of controlling gestational diabetes mellitus : A systematic review. In: European Journal of Health Economics. 2019 ; Vol. 20, No. 3. pp. 407-417.

Harvard

Fitria, N, van Asselt, ADI & Postma, MJ 2019, 'Cost-effectiveness of controlling gestational diabetes mellitus: A systematic review', European Journal of Health Economics, vol. 20, no. 3, pp. 407-417. https://doi.org/10.1007/s10198-018-1006-y

Standard

Cost-effectiveness of controlling gestational diabetes mellitus : A systematic review. / Fitria, Najmiatul; van Asselt, Antoinette D. I.; Postma, Maarten J.

In: European Journal of Health Economics, Vol. 20, No. 3, 04.2019, p. 407-417.

Research output: Contribution to journalArticleAcademicpeer-review

Vancouver

Fitria N, van Asselt ADI, Postma MJ. Cost-effectiveness of controlling gestational diabetes mellitus: A systematic review. European Journal of Health Economics. 2019 Apr;20(3):407-417. https://doi.org/10.1007/s10198-018-1006-y


BibTeX

@article{ca47655e6c0b4b1cbf0c4bee66ed417d,
title = "Cost-effectiveness of controlling gestational diabetes mellitus: A systematic review",
abstract = "OBJECTIVE: Timely screening for hyperglycaemia in pregnancy using a simple glucose test enhances early detection and control of gestational diabetes mellitus (GDM). The aim of this study was to provide an overview of the evidence on the cost-effectiveness of identification and/or treatment of GDM.METHODS: We conducted a systematic review using three electronic databases (PubMed, EMBASE, and Cochrane) of cost-effectiveness studies of GDM screening and treatment published during 2000-2017.RESULTS: The initial search discovered 287 references (PubMed 86, EMBASE 195, Cochrane library 6) of which six full articles were included in the review. Two articles were model-based analysis and the remaining four were trial based. Two studies demonstrated favorable cost-effectiveness of intensified management of mild GDM. In the other included studies, neither screening nor treatment of GDM was shown to be cost effective, although results varied with the particular outcome measures used and the assumptions that where applied.CONCLUSION: Neither screening nor treating GDM seems to be convincingly cost-effective from the studies reviewed. However, all studies were done in high-income countries with obviously different health systems than low-/middle-income countries (LMIC) have. Since detection of GDM may be relatively poor in LMIC, screening might be more worthwhile in these countries. Comprehensive research is necessary in LMIC, including the potential outcomes of assessing its cost-effectiveness. Favorable cost-effectiveness could help in bridging the need for and access to increased diabetes screening in early pregnancy in these countries.",
author = "Najmiatul Fitria and {van Asselt}, {Antoinette D. I.} and Postma, {Maarten J.}",
year = "2019",
month = "4",
doi = "10.1007/s10198-018-1006-y",
language = "English",
volume = "20",
pages = "407--417",
journal = "European Journal of Health Economics",
issn = "1618-7598",
publisher = "Springer Verlag",
number = "3",

}

RIS

TY - JOUR

T1 - Cost-effectiveness of controlling gestational diabetes mellitus

T2 - A systematic review

AU - Fitria, Najmiatul

AU - van Asselt, Antoinette D. I.

AU - Postma, Maarten J.

PY - 2019/4

Y1 - 2019/4

N2 - OBJECTIVE: Timely screening for hyperglycaemia in pregnancy using a simple glucose test enhances early detection and control of gestational diabetes mellitus (GDM). The aim of this study was to provide an overview of the evidence on the cost-effectiveness of identification and/or treatment of GDM.METHODS: We conducted a systematic review using three electronic databases (PubMed, EMBASE, and Cochrane) of cost-effectiveness studies of GDM screening and treatment published during 2000-2017.RESULTS: The initial search discovered 287 references (PubMed 86, EMBASE 195, Cochrane library 6) of which six full articles were included in the review. Two articles were model-based analysis and the remaining four were trial based. Two studies demonstrated favorable cost-effectiveness of intensified management of mild GDM. In the other included studies, neither screening nor treatment of GDM was shown to be cost effective, although results varied with the particular outcome measures used and the assumptions that where applied.CONCLUSION: Neither screening nor treating GDM seems to be convincingly cost-effective from the studies reviewed. However, all studies were done in high-income countries with obviously different health systems than low-/middle-income countries (LMIC) have. Since detection of GDM may be relatively poor in LMIC, screening might be more worthwhile in these countries. Comprehensive research is necessary in LMIC, including the potential outcomes of assessing its cost-effectiveness. Favorable cost-effectiveness could help in bridging the need for and access to increased diabetes screening in early pregnancy in these countries.

AB - OBJECTIVE: Timely screening for hyperglycaemia in pregnancy using a simple glucose test enhances early detection and control of gestational diabetes mellitus (GDM). The aim of this study was to provide an overview of the evidence on the cost-effectiveness of identification and/or treatment of GDM.METHODS: We conducted a systematic review using three electronic databases (PubMed, EMBASE, and Cochrane) of cost-effectiveness studies of GDM screening and treatment published during 2000-2017.RESULTS: The initial search discovered 287 references (PubMed 86, EMBASE 195, Cochrane library 6) of which six full articles were included in the review. Two articles were model-based analysis and the remaining four were trial based. Two studies demonstrated favorable cost-effectiveness of intensified management of mild GDM. In the other included studies, neither screening nor treatment of GDM was shown to be cost effective, although results varied with the particular outcome measures used and the assumptions that where applied.CONCLUSION: Neither screening nor treating GDM seems to be convincingly cost-effective from the studies reviewed. However, all studies were done in high-income countries with obviously different health systems than low-/middle-income countries (LMIC) have. Since detection of GDM may be relatively poor in LMIC, screening might be more worthwhile in these countries. Comprehensive research is necessary in LMIC, including the potential outcomes of assessing its cost-effectiveness. Favorable cost-effectiveness could help in bridging the need for and access to increased diabetes screening in early pregnancy in these countries.

U2 - 10.1007/s10198-018-1006-y

DO - 10.1007/s10198-018-1006-y

M3 - Article

VL - 20

SP - 407

EP - 417

JO - European Journal of Health Economics

JF - European Journal of Health Economics

SN - 1618-7598

IS - 3

ER -

ID: 65343782